Clinical Trials eConsent: The Complete Guide for 2026

The world of clinical research is moving fast, and the traditional informed consent process based on paper is being replaced by a smarter, more efficient alternative, electronic consent (eConsent). At its core, eConsent is the use of digital tools (like tablets, computers, or smartphones) to share information about a research study and to securely document a participant’s consent. This digital approach, often using tools built for the purpose of compliant consenting, is changing how participants learn about and agree to join studies, making the entire process more transparent, engaging, and compliant.

If you are a researcher, sponsor, or healthcare professional, understanding the ins and outs of eConsent is no longer optional. This guide breaks down everything you need to know, from the basic definition to the complex regulatory requirements, all in a straightforward and human way.

What is eConsent in clinical trials? A Clear Definition

Electronic informed consent (eConsent) is the use of digital tools like tablets, computers, or smartphones to share information about a research study and to document a participant’s consent. Instead of signing a stack of papers, participants interact with the information on a screen.

This is more than just a PDF of a paper form. A true eConsent process often uses interactive elements like videos, graphics, and quizzes to improve understanding. The participant provides their agreement with a secure electronic signature. Crucially, any eConsent system must follow the same strict ethical and legal standards as paper consent, as confirmed by FDA and HHS guidelines. For a broader market snapshot, see our guide to the top eConsent software in 2025.

The industry has embraced this shift, particularly as decentralized and hybrid trials become more common. By 2018, all of the top ten pharmaceutical companies had an eConsent strategy in place, recognizing its power to create trials that are more friendly for patients and more efficient.

The Key Benefits of Using eConsent

Switching from paper to an electronic system offers huge advantages for everyone involved in a clinical trial. The benefits of using an eConsent platform go far beyond simple convenience.

• Better Participant Understanding: Studies consistently show that interactive eConsent improves how well participants understand trial information. Participants have been shown to spend significantly more time reviewing interactive eConsent materials compared to paper forms with identical information.
• Fewer Errors and Better Compliance: Paperwork is prone to mistakes like missing signatures or using outdated forms, which are common findings in regulatory audits. An eConsent system prevents these errors by requiring all fields to be completed and ensuring only the current, IRB approved version is used.
• Greater Accessibility and Reach: Remote eConsent removes geographic barriers, allowing people to join studies without needing to travel to a site just to sign a form. This is especially helpful for reaching diverse or underserved populations.
• Improved Engagement and Satisfaction: Participants can review information at their own pace and use interactive tools to clarify complex topics. Electronic consent often leads to higher satisfaction scores from participants.
• Oversight in Real Time: Sponsors and study managers get an instant view of consent status across all sites with reporting and oversight dashboards in real time. This transparency helps manage enrollment and identify potential issues early, all without waiting for paper forms to be collected and reviewed.

Core Components of a Modern eConsent System

A robust eConsent platform is built on several key technological and procedural components that work together to ensure a smooth and compliant process.

The Multimedia Component

The multimedia component is what truly sets eConsent apart from paper. It involves using videos, animations, audio narration, and interactive graphics to explain the study. For example, a short video can summarize the study’s purpose in simple terms, or an interactive diagram can show how an investigational device works. Research has shown that using multimedia like this can significantly increase participant comprehension and satisfaction.

Assessing Participant Comprehension

Ensuring a participant truly understands the study is a core ethical requirement. Modern eConsent platforms move beyond a simple signature to actively assess comprehension. This is often done through:

• Knowledge Checks: These are short, embedded quizzes or questions that appear after key sections of the consent form. They test understanding of critical concepts like study procedures, risks, and the right to withdraw. Incorrect answers can trigger the system to provide clarifying information or flag the topic for discussion with study staff.
• Interactive Assessments: Some platforms use more advanced methods to gauge understanding, helping to confirm that consent is truly informed. This helps satisfy regulatory expectations and reduces the risk of participants dropping out later because they misunderstood the study requirements.

Electronic Signatures (eSignatures)

An electronic signature is a digital mark of a person’s intent to sign the consent form. This can be done by typing a name, drawing a signature on a touchscreen, or clicking an “I Agree” button. U.S. regulations, including the ESIGN Act of 2000, give eSignatures the same legal weight as handwritten ones, as long as they are captured in a secure and verifiable way.

Version Control for Consent Materials

Clinical trial protocols and consent forms often change. Version control is a critical feature of any eConsent system that ensures participants are only ever shown the most recent, IRB approved version of the consent form. When a new version is approved, the system can automatically prompt existing participants to be reconsented, all while maintaining a clear audit trail of which version each participant signed and when. This prevents a common and serious compliance error.

How Does the eConsent Process Work?

The eConsent process can be adapted to different study needs, whether it happens at a clinic or in a participant’s home.

The In Person eConsent Process

In an in person setting, a participant is typically given a tablet or directed to a computer at the research site. They can review the eConsent materials in a private room at their own pace. A key advantage here is that a study coordinator or investigator is physically present to answer questions immediately. After the participant has reviewed the material and had their questions answered, they sign the form electronically on the device.

The Remote eConsent Process

For decentralized or hybrid trials, the remote eConsent process is essential. A potential participant receives a secure link via email or text message. They can then review the consent form on their own device from anywhere with an internet connection. The process must include a clear way for them to ask questions, such as a phone number to call, a chat feature, or a scheduled telehealth visit with the study team before they sign.

Key Implementation Considerations for eConsent

Successfully launching an eConsent solution requires careful planning. You need to think about technology, workflows, and regulatory requirements before you begin.

• Data Security and Privacy: The platform must protect personal health information using tools like encryption and secure access controls.
• Workflow Integration: Think about how the digital process will fit with your site’s current procedures for consenting participants.
• Participant Accessibility: Ensure the system is easy to use for people with varying levels of tech skill and consider providing devices on site if needed.
• Identity Verification: For remote consent, have a reliable method to confirm that the person signing is who they say they are.
• Training and Support: Proper training for site staff and participants is essential for a smooth rollout. This includes providing resources like helpdesks, FAQs, and office hours to address questions promptly.

For organizations looking to streamline this process, working with an experienced partner can make all the difference. An integrated eClinical platform from Curebase can provide a validated system with built in compliance features, simplifying the implementation steps for your study team.

Navigating Regulatory Compliance for eConsent

Compliance is the foundation of any valid consent process. With eConsent, this means meeting the same ethical standards as paper plus adhering to rules for electronic records.

Global and Local Regulations

An eConsent process must meet all the requirements of regulations like the FDA’s 21 CFR Part 50 and the HHS 45 CFR Part 46 (the Common Rule). For global trials, compliance extends to international standards such as the GDPR in Europe, which has strict rules for data protection and consent. The electronic format is simply the medium; the ethical obligations remain unchanged.

Understanding 21 CFR Part 11 Compliance

For any trial regulated by the FDA, 21 CFR Part 11 is a critical piece of the puzzle. This rule sets the standards for electronic records and signatures to be considered as trustworthy and reliable as paper. A Part 11 compliant eConsent system must have features like system validation, secure user access, and a complete, uneditable audit trail that logs every action.

Secure Attestation and Documentation

A compliant eConsent system doesn’t just capture a signature; it creates a detailed and secure record of the entire consent process. This includes a verifiable audit trail that records who accessed the form, when they accessed it, and every action taken. This documentation is crucial for regulatory inspections, as it proves that the consent was obtained properly and in accordance with the approved protocol.

Ensuring HIPAA Compliance

In the U.S., the Health Insurance Portability and Accountability Act (HIPAA) governs the use of protected health information (PHI). If an eConsent platform collects or stores PHI, it must have strong safeguards in place, including encryption and strict access controls. The vendor providing the platform may also need to sign a Business Associate Agreement (BAA) with the research site.

Preparing Your IRB Application

Your Institutional Review Board (IRB) must approve both the content of your eConsent form and the electronic process itself. The IRB’s review ensures the process is ethically sound and protects participants. When you prepare your IRB application, you should include:

1. The full text and a description of any multimedia elements.
2. A step by step explanation of how the eConsent process will work.
3. Details on how participants can ask questions and interact with staff.
4. Information on the platform’s security, data storage, and confidentiality measures.

Special Considerations in the Consent Process

The consenting process sometimes involves more than just the participant. A flexible eConsent system must be able to handle these common scenarios.

Legally Authorized Representatives (LARs)

When a participant cannot consent for themselves (for instance, due to cognitive impairment), a Legally Authorized Representative (LAR) must provide consent on their behalf. The eConsent system should have a workflow that allows an LAR to review the information and sign, with the system clearly documenting that the signature was provided by an LAR.

Assent Documentation for Minors

For studies involving children, you typically need both parental permission (consent) and the child’s agreement (assent). The assent process involves explaining the study to the child in language appropriate for their age. An eConsent platform can support this with a separate, simplified assent form that might use animation or simple graphics. The system should be able to capture the child’s electronic signature or checkbox agreement, in addition to the parent’s signature on the main consent form.

Impartial Witness and Interpreter Support

In situations where a participant is unable to read or has limited English proficiency, regulations often require an impartial witness and or an interpreter to be present during the consent discussion. An eConsent system can accommodate this by providing a dedicated workflow with separate signature lines for the witness or interpreter on the electronic form. For remote consenting, this process can be handled through a video conference with multiple parties where all individuals can review and sign the document in real time.

Multilingual Support

To improve diversity and inclusion in clinical trials, eConsent platforms must support multiple languages. This involves more than just direct translation. The content should be culturally adapted to ensure it is understood correctly in different regions. A robust platform will allow study teams to manage and deploy multiple language versions of the consent form, ensuring that participants receive the information in the language they are most comfortable with.

Providing a Copy of the Signed Consent

Regulations require that every participant receives a copy of the consent form they signed. An eConsent system makes this easy. After signing, a PDF copy of the completed form can be automatically emailed to the participant or made available for them to download from a secure portal.

The Future of eConsent: Trends to Watch

The technology behind eConsent is constantly evolving, driven by a focus on patient centricity and data integration. As we look toward the future, several key trends are shaping the next generation of electronic consent.

The Rise of AI and Automation

Artificial intelligence (AI) is beginning to play a role in making consent forms more understandable. Tools powered by AI can help simplify complex medical language or even generate summaries of study information that are friendly for patients. Chatbots are also being explored as a way to provide instant answers to common participant questions during the consent process, improving engagement and comprehension.

Advanced Security: Biometrics and Blockchain

While current security standards are robust, future eConsent platforms may incorporate even more advanced measures. Biometric verification, such as fingerprint or facial recognition, could offer an additional layer of identity confirmation for remote consenting. Blockchain technology is also being explored for its potential to create a decentralized and tamper proof ledger of consent records, further enhancing data integrity and security.

eConsent’s Role in Real World Evidence (RWE)

As clinical research expands to include real world evidence (RWE), eConsent is a critical tool for obtaining permission to collect data from sources like electronic health records (EHRs) and wearable devices. A flexible eConsent platform can help explain how this real world data will be used and allow participants to provide specific permissions, supporting the generation of valuable insights outside of traditional trial settings.

Integrating eConsent with Other Systems

The true power of digital tools is realized when they work together. Integrating your eConsent solution with other clinical systems can create massive efficiencies. Pairing eConsent with an integrated EDC streamlines downstream data capture, monitoring, and audit trails.

EMR and EHR Integration

Integrating an eConsent platform with a site’s Electronic Medical Record (EMR) or Electronic Health Record (EHR) system can streamline workflows. For example, once a patient is identified as a potential study candidate in the EHR, the system could automatically trigger an invitation to the eConsent platform. After consent is signed, a copy of the completed form can be automatically filed back into the patient’s electronic record, ensuring a complete and accessible source of truth.

Using REDCap for eConsent: Setup and Best Practices

REDCap (Research Electronic Data Capture) is a popular tool at many academic institutions that can be used to create a basic eConsent workflow.

Setting it up generally involves building the consent form as a REDCap survey, enabling the eConsent Framework, and adding a signature field. Many institutions provide project templates pre built in REDCap to simplify this process. The framework adds a certification page where participants confirm their responses before submission, and it automatically archives a PDF copy.

However, it’s important to understand REDCap’s limitations. Most standard REDCap installations are not 21 CFR Part 11 compliant out of the box, making them unsuitable for many FDA regulated trials unless the institution has specifically validated their instance. For these regulated studies, dedicated eConsent platforms that are built with these compliance features are often a more robust and reliable choice. If you need an end to end approach, explore decentralized clinical trials technology for a complete setup.

To gain IRB approval for using REDCap for eConsent, your submission should include a PDF copy of the consent instrument, details on the process for identity verification, and an explanation of how participants will receive a copy of the signed form.

Training and Resources for REDCap eConsent

For teams new to using REDCap for eConsent, several resources can help ensure a compliant and effective setup. Many universities and institutions that provide REDCap also offer dedicated support and training materials. These often include detailed guides, video tutorials, and direct email support for specific questions. The official REDCap project website hosts extensive documentation and video libraries that cover core functionalities, including the eConsent framework. Additionally, the built in “Help & FAQ” section within your local REDCap installation is a valuable first stop for troubleshooting and learning best practices.

The move to eConsent is a clear step forward for clinical research, offering a more engaging, compliant, and efficient path to enrolling participants. By embracing this technology, study teams can reduce administrative burdens and focus on what truly matters, which is advancing science and improving patient outcomes.

Ready to see how a modern eConsent solution can transform your clinical trials? Schedule a demo to see the platform in action.

eConsent Frequently Asked Questions (FAQ)

1. Is eConsent legally binding?
Yes. When implemented correctly according to regulations like the U.S. ESIGN Act and 21 CFR Part 11, electronic signatures are legally valid and hold the same weight as handwritten signatures.

2. Can eConsent be used for any type of clinical trial?
Yes, eConsent is suitable for nearly all types of clinical trials, from simple observational studies to complex, regulated drug and device trials. The key is ensuring the platform and process meet the specific regulatory requirements for your study.

3. Do participants need their own device to use eConsent?
Not necessarily. For remote consent, participants use their own computer or smartphone. For studies conducted at a clinic, sites can provide a sanitized tablet for participants to use on site.

4. What happens if the consent form is updated during a study?
A major benefit of an eConsent system is version control. When an updated form is approved by the IRB, the system makes it the new standard. It can then automatically notify previously enrolled participants that they need to review and sign the new version (a process called reconsenting).

5. How does eConsent improve participant diversity?
By enabling remote consent, eConsent removes the barrier of travel. This allows researchers to recruit participants from a much wider geographic area, making it easier to enroll a population that is more representative of the real world. Tools like Curebase Campaigns help study teams run targeted, compliant participant recruitment at scale.